Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Gynecologic Oncology|September 27, 2021
Clinical outcome in patients with primary epithelial ovarian cancer and germline BRCA1/2-mutation - real life dataBeyhan Ataseven, Denise Tripon, Richard Schwameis, et al.
Data in Brief|May 13, 2020
Dataset on patients with Recurrent Borderline Ovarian Tumors and Table with Review of Literature on Fertility and Oncologic Outcomes of patients with Borderline Ovarian TumorsHelmut Plett, Enzo Ricciardi, Philipp Harter, et al.
Gynecologic Oncology|June 26, 2019
Low anterior resection syndrome (LARS) in patients with epithelial ovarian cancer after primary debulking surgeryMarlene Kranawetter, Beyhan Ataseven, Christoph Grimm, et al.
Archives of Gynecology and Obstetrics|March 12, 2021
Modern day screening for Lynch syndrome in endometrial cancer: the KEM experienceNina Pauly, Thaïs Baert, Rita Schmutzler, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 29, 2022
Ovarian cancer onset across different BRCA mutation types: a view to a more tailored approach for BRCA mutated patientsClaudia Marchetti, Beyhan Ataseven, Chiara Cassani, et al.
Gynecologic Oncology|September 7, 2024
Impact of adjuvant therapy on oncologic outcomes in uterine-confined clear cell carcinoma of the endometriumEric Rios-Doria, Silvana Pedra Nobre, Dib Sassine, et al.
Breast (Edinburgh, Scotland)|February 29, 2024
Breast-conserving surgery is not associated with increased local recurrence in patients with early-stage node-negative triple-negative breast cancer treated with neoadjuvant chemotherapyDavid Krug, Valentina Vladimirova, Michael Untch, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 13, 2019
Perception of side effects associated with anticancer treatment in women with breast or ovarian cancer (KEM-GO-1): a prospective trialBeyhan Ataseven, Johanna Frindte, Philipp Harter, et al.
Molecular Oncology|April 14, 2023
Prognostic and predictive impact of gene expression in node-positive early breast cancer patients receiving dose-dense versus standard-dose adjuvant chemotherapyMattea Reinisch, Simona Bruzas, Oleg Gluz, et al.
Gynecologic Oncology|May 24, 2024
Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational statusClaudia Marchetti, Beyhan Ataseven, Anna M Perrone, et al.
Pageof 11